Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,462 total articles
We expect the US dollar to face cyclical pressure over the coming weeks to months. Tactical longs in EUR/USD and AUD/USD and a short on the DXY offer asymmetric risk-reward if US yields soften and external growth momentum reasserts. The plan below includes exact entries, stops and targets with horizon guidance and clear risk points.
Compass Pathways (CMPS) is a beaten-down biotech turned momentum leader after regulatory acceleration and positive Phase 3 data for COMP360. The stock is richly priced for a biotech but fundamentals and market structure (heavy short interest and large short volume on 04/20/2026) create a tactical long opportunity. This trade idea lays out entry, st…
Equity Bancshares (EQBK) looks like a pragmatic buy here: the stock sits below $1 billion market cap, generates meaningful free cash flow, and has a recent history of earnings beats and targeted M&A. Valuation metrics are not demanding on a price-to-book basis, short interest is elevated, and technicals are neutral-to-bullish. This trade lays out a…
BridgeBio (BBIO) is staging a transition from a pure rare-disease developer to a commercial-stage company with optionality for oncology expansion. Recent wins (Attruby long-term mortality data, positive BBP-418 Phase 3 readout, achondroplasia data) should drive revenue and M&A firepower that could be redeployed into KRAS-targeted assets or partners…
Valero’s refining cash flow has surged amid diesel and gasoline spikes, producing free cash flow of roughly $3.7B and a balance sheet that supports outsized capital returns. With the stock trading near $229, we outline a mid-term long trade designed to capture roughly 14% upside to $261 while protecting capital with a $215 stop.
United Natural Foods (UNFI) looks set to keep climbing from here: improving adjusted EPS, positive free cash flow, and a valuation that implies limited expectations create room for upside. Expect gains to be measured rather than explosive — buy size accordingly and use a tight stop.
Jacobs Solutions (J) posts healthy margins, solid cash flow and a rising dividend, yet recent price action shows muted investor appetite and elevated short activity. That divergence creates a tactical mid-term long trade: enter near current levels, keep a disciplined stop, and target a move back toward the $140s as the market re-prices durable cash…
Suncor's integrated footprint, heavy-crude exposure and solid dividend make it my top Canada energy pick on a post-conflict crude price regime. I'm raising my buy-on-weakness limit to $55/share, with a $72 target and a $50 hard stop, sized for a mid-term rebound tied to sustained oil strength and improving refining margins.
Taiwan Semiconductor Manufacturing (TSM) is trading nearer to the cyclical trough than to the structural growth story the company now represents. Strong Q1 prints, a 72% foundry share, and analyst forecasts of high-teens to 40%+ earnings growth support a long-biased trade on a near-term pullback. Entry $362.00, stop $338.00, target $420.00 for a lo…
Accenture's combination of scale, cash generation and targeted AI M&A/partnerships creates a low-hanging path to margin expansion and share gains in consulting, cloud migration and cybersecurity. We initiate a tactical long with precise entry, stop and two upside targets tied to catalysts over the next 46-180 trading days.
Candel Therapeutics (CADL) looks like a constructive buy right now. Positive clinical readouts, a funded commercialization push and bullish technical momentum have pushed the stock toward a new 52-week high. With market cap near $545M, meaningful cash on the balance sheet and a clear product roadmap, a disciplined long position offers asymmetric up…
An anticipated SpaceX IPO at a $1.75 trillion valuation and a jaw-dropping 220x EV/EBITDA multiple could catalyze a broad re-rating across aerospace & defense. That repricing would lift multiples for primes, launch suppliers, and satellite-capable contractors. Tactical trade: go long the iShares U.S. Aerospace & Defense ETF (ITA) to capture a secto…
Qfin trades at bargain-bin multiples and an eye-catching 10%+ yield, yet a tightening regulatory environment for consumer lending in China has turned tomorrow’s earnings and dividend into catalysts and potential landmines. This trade idea targets a mid-term rebound while respecting regulatory uncertainty and the upcoming ex-dividend date.
Agnico Eagle's string of strategic buys — including consolidation in Finland and the Fingold purchase — materially expands low-risk, high-return optionality. At a $105.7B market cap and a P/E of 24.3, the stock already reflects quality; I argue the market is under-pricing the production and synergy upside from the new district consolidation. Action…
Patria has strengthened scale and diversified revenue with three sizeable acquisitions that materially lift Fee-Earning AUM and Fee Related Earnings. The stock is a buy from a fundamentals perspective, but after a busy M&A stretch I favor a tactical, size-conscious long with a clear stop and a mid- to multi-month target.
SKYX Platforms (SKYX) has stacked strategic partnerships, retail launches, and institutional capital in recent quarters. That combination creates a clear mid-term re-rating pathway if deployments and AI-enabled features gain commercial traction. At the same time the company is unprofitable, burning cash, and sitting in a crowded short-interest prof…
Marvell is trading at market highs but the fundamentals and cash generation argue for additional upside as AI infrastructure spending accelerates. Strong free cash flow, healthy margins and strategic partnerships (including Nvidia and hyperscalers) support a long trade with a 180-trading-day horizon. Manage risk with a clear stop below $140.
Ciena is shifting from carrier-led recovery to a data-center-driven growth phase. Strong fiscal results, a multi-billion order backlog and outsized exposure to AI-optimized optical interconnects justify a long trade at current levels with a clear stop and a price target that assumes continued backlog conversion and margin leverage.
OneMain offers an attractive current yield near 7%, a sub-10x earnings multiple and deep trading liquidity. Use a disciplined entry at the current price, a clear stop below SMA50, and a two-stage upside target that captures both income and capital appreciation while respecting regulatory/legal risk.
CoreWeave is routing GPU capacity into long-term contracts and scaling capacity aggressively. The market cap and backlog dynamics imply upside that isn't fully baked into current multiples. This trade targets that re-pricing with an entry at $119.50, a stop at $95.00, and a primary target of $160.00 over a mid-term horizon.
Cameco (CCJ) is positioned to benefit from a multi-year nuclear build cycle and near-term demand shocks. With momentum intact and strong fundamentals, I recommend a tactical swing long if the stock trades below $120, targeting $135 with a $109 stop. This is a medium-risk swing trade for patient traders looking to capture a move back toward the 52-w…
Sohu (SOHU) trades at a market cap of about $415m despite a Q4 2025 quarter that produced $142m in revenue and GAAP net income of $123m after a $285m tax reversal. Guidance for Q1 is weak, but the combination of one-time accounting gains, a profitable gaming arm and low float means a disciplined long with tight risk controls can capture a re-rate i…
Berkshire Hathaway offers a rare mix of scale, a huge cash war chest, and a fresh CEO willing to redeploy capital. With the shares trading at a modest multiple (PE ~15, P/B ~1.42) and technical momentum soft, the next 45-180 trading days present a tradeable opportunity: buy into disciplined capital redeployment and potential buybacks while protecti…
Apple is entering a leadership reset that pressures sentiment but creates a clear, tradable setup. I recommend a swing trade long on AAPL around current levels with a $300 target over the next 45 trading days, banking on investor relief, product cadence clarity, and the quicker monetization path of a licensed Siri API rather than a costly internal …
Kyverna reported a positive Phase 2 readout for KYV-101 that sent the stock higher on heavy volume. The clinical signal and clear registrational path justify a speculative long, but the sample size is small, fundamentals remain cash-burning, and technicals are extended. This trade idea lays out an entry, stop, and target for a mid-term swing (45 tr…
